ID   S4A4_RAT                Reviewed;        1079 AA.
AC   Q9JI66; O35422; O54815; Q9JJ32; Q9QXH6;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   29-MAY-2024, entry version 149.
DE   RecName: Full=Electrogenic sodium bicarbonate cotransporter 1;
DE            Short=Sodium bicarbonate cotransporter;
DE   AltName: Full=NBC-like protein;
DE   AltName: Full=Na(+)/HCO3(-) cotransporter;
DE   AltName: Full=Solute carrier family 4 member 4;
GN   Name=Slc4a4; Synonyms=Nbc, Nbc1, Nbce1, Rnbc1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, TISSUE SPECIFICITY,
RP   SUBCELLULAR LOCATION, AND TRANSPORTER ACTIVITY.
RC   TISSUE=Kidney cortex;
RX   PubMed=9486238; DOI=10.1152/ajprenal.1998.274.2.f425;
RA   Romero M.F., Fong P., Berger U.V., Hediger M.A., Boron W.F.;
RT   "Cloning and functional expression of rNBC, an electrogenic Na(+)-HCO3-
RT   cotransporter from rat kidney.";
RL   Am. J. Physiol. 274:F425-F432(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, AND INDUCTION.
RC   STRAIN=Sprague-Dawley; TISSUE=Kidney;
RX   PubMed=9841505; DOI=10.1152/ajprenal.1998.274.6.f1119;
RA   Burnham C.E., Flagella M., Wang Z., Amlal H., Shull G.E., Soleimani M.;
RT   "Cloning, renal distribution, and regulation of the rat Na+-HCO3-
RT   cotransporter.";
RL   Am. J. Physiol. 274:F1119-F1126(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), FUNCTION, ACTIVITY
RP   REGULATION, TISSUE SPECIFICITY, AND TRANSPORTER ACTIVITY.
RC   TISSUE=Brain;
RX   PubMed=10837348; DOI=10.1152/ajpcell.2000.278.6.c1200;
RA   Bevensee M.O., Schmitt B.M., Choi I., Romero M.F., Boron W.F.;
RT   "An electrogenic Na(+)-HCO3(-) cotransporter (NBC) with a novel COOH-
RT   terminus, cloned from rat brain.";
RL   Am. J. Physiol. 278:C1200-C1211(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   DEVELOPMENTAL STAGE, AND TRANSPORTER ACTIVITY.
RC   TISSUE=Brain;
RX   PubMed=10648705; DOI=10.1523/jneurosci.20-03-01001.2000;
RA   Giffard R.G., Papadopoulos M.C., van Hooft J.A., Xu L., Giuffrida R.,
RA   Monyer H.;
RT   "The electrogenic sodium bicarbonate cotransporter: developmental
RT   expression in rat brain and possible role in acid vulnerability.";
RL   J. Neurosci. 20:1001-1008(2000).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=11592950; DOI=10.1152/ajprenal.2001.281.5.f920;
RA   Bok D., Schibler M.J., Pushkin A., Sassani P., Abuladze N., Naser Z.,
RA   Kurtz I.;
RT   "Immunolocalization of electrogenic sodium-bicarbonate cotransporters pNBC1
RT   and kNBC1 in the rat eye.";
RL   Am. J. Physiol. 281:F920-F935(2001).
RN   [6]
RP   INDUCTION.
RX   PubMed=11703600; DOI=10.1046/j.1523-1755.2001.00995.x;
RA   Amlal H., Chen Q., Greeley T., Pavelic L., Soleimani M.;
RT   "Coordinated down-regulation of NBC-1 and NHE-3 in sodium and bicarbonate
RT   loading.";
RL   Kidney Int. 60:1824-1836(2001).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=12444017; DOI=10.1152/ajpcell.00166.2002;
RA   Satoh H., Moriyama N., Hara C., Yamada H., Horita S., Kunimi M.,
RA   Tsukamoto K., Iso-O N., Inatomi J., Kawakami H., Kudo A., Endou H.,
RA   Igarashi T., Goto A., Fujita T., Seki G.;
RT   "Localization of Na+-HCO-3 cotransporter (NBC-1) variants in rat and human
RT   pancreas.";
RL   Am. J. Physiol. 284:C729-C737(2003).
RN   [8]
RP   MUTAGENESIS OF ASN-33; ASN-199; ASN-208; ASN-497; ASN-592; ASN-597 AND
RP   ASN-617 (ISOFORM 2), GLYCOSYLATION AT ASN-597 AND ASN-617 (ISOFORM 2),
RP   FUNCTION, AND TRANSPORTER ACTIVITY.
RX   PubMed=12604466; DOI=10.1152/ajprenal.00131.2002;
RA   Choi I., Hu L., Rojas J.D., Schmitt B.M., Boron W.F.;
RT   "Role of glycosylation in the renal electrogenic Na+-HCO3-cotransporter
RT   (NBCe1).";
RL   Am. J. Physiol. 284:F1199-F1206(2003).
RN   [9]
RP   TISSUE SPECIFICITY.
RX   PubMed=15329059; DOI=10.1111/j.1365-201x.2004.01297.x;
RA   Kristensen J.M., Kristensen M., Juel C.;
RT   "Expression of Na+/HCO3- co-transporter proteins (NBCs) in rat and human
RT   skeletal muscle.";
RL   Acta Physiol. Scand. 182:69-76(2004).
RN   [10]
RP   INDUCTION.
RX   PubMed=15781297; DOI=10.1016/j.taap.2004.08.021;
RA   Ahn D.-W., Chung J.-M., Kim J.-Y., Kim K.-R., Park Y.-S.;
RT   "Inhibition of renal Na+/H+ exchange in cadmium-intoxicated rats.";
RL   Toxicol. Appl. Pharmacol. 204:91-98(2005).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-68; SER-245; THR-249;
RP   THR-254; SER-257; SER-262; SER-1029; SER-1034 AND SER-1069, PHOSPHORYLATION
RP   [LARGE SCALE ANALYSIS] AT SER-2 (ISOFORM 2), PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-1026; SER-1029; SER-1060; SER-1064 AND SER-1078 (ISOFORM
RP   3), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Electrogenic sodium/bicarbonate cotransporter with a
CC       Na(+):HCO3(-) stoichiometry varying from 1:2 to 1:3. May regulate
CC       bicarbonate influx/efflux at the basolateral membrane of cells and
CC       regulate intracellular pH. {ECO:0000269|PubMed:10648705,
CC       ECO:0000269|PubMed:10837348, ECO:0000269|PubMed:12604466,
CC       ECO:0000269|PubMed:9486238}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 hydrogencarbonate(out) + Na(+)(out) = 2
CC         hydrogencarbonate(in) + Na(+)(in); Xref=Rhea:RHEA:72215,
CC         ChEBI:CHEBI:17544, ChEBI:CHEBI:29101;
CC         Evidence={ECO:0000269|PubMed:10648705, ECO:0000269|PubMed:10837348};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3 hydrogencarbonate(out) + Na(+)(out) = 3
CC         hydrogencarbonate(in) + Na(+)(in); Xref=Rhea:RHEA:72219,
CC         ChEBI:CHEBI:17544, ChEBI:CHEBI:29101;
CC         Evidence={ECO:0000269|PubMed:10648705, ECO:0000269|PubMed:10837348};
CC   -!- CATALYTIC ACTIVITY: [Isoform 2]:
CC       Reaction=2 hydrogencarbonate(out) + Na(+)(out) = 2
CC         hydrogencarbonate(in) + Na(+)(in); Xref=Rhea:RHEA:72215,
CC         ChEBI:CHEBI:17544, ChEBI:CHEBI:29101;
CC         Evidence={ECO:0000269|PubMed:12604466, ECO:0000269|PubMed:9486238};
CC   -!- CATALYTIC ACTIVITY: [Isoform 2]:
CC       Reaction=3 hydrogencarbonate(out) + Na(+)(out) = 3
CC         hydrogencarbonate(in) + Na(+)(in); Xref=Rhea:RHEA:72219,
CC         ChEBI:CHEBI:17544, ChEBI:CHEBI:29101;
CC         Evidence={ECO:0000269|PubMed:12604466, ECO:0000269|PubMed:9486238};
CC   -!- ACTIVITY REGULATION: Inhibited by 4,4'-diisothiocyanatostilbene-2,2'-
CC       disulfonic acid (DIDS). {ECO:0000269|PubMed:10837348}.
CC   -!- SUBUNIT: Homodimer. Interacts with CA2/carbonic anhydrase 2 and
CC       CA4/carbonic anhydrase 4 which may regulate transporter activity.
CC       Isoform 1 but not isoform 2 interacts with AHCYL1 (via PEST domain when
CC       phosphorylated); the interaction increases SLC4A4 isoform 1 activity.
CC       Interacts with AHCYL2. {ECO:0000250|UniProtKB:O88343,
CC       ECO:0000250|UniProtKB:Q9GL77, ECO:0000250|UniProtKB:Q9Y6R1}.
CC   -!- SUBCELLULAR LOCATION: Basolateral cell membrane
CC       {ECO:0000305|PubMed:10837348}; Multi-pass membrane protein
CC       {ECO:0000255}. Cell membrane {ECO:0000250|UniProtKB:Q9Y6R1}; Multi-pass
CC       membrane protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=bNBC1, NBCe1-B, pNBC1, pNBC-1, rb1NBC;
CC         IsoId=Q9JI66-1; Sequence=Displayed;
CC       Name=2; Synonyms=kNBC1, kNBC-1, NBCe1-A, rkNBC, rkNBC1;
CC         IsoId=Q9JI66-2; Sequence=VSP_016717, VSP_016718;
CC       Name=3; Synonyms=NBCe1-C, rb2NBC;
CC         IsoId=Q9JI66-3; Sequence=VSP_016719;
CC   -!- TISSUE SPECIFICITY: Specifically expressed in kidney and to a lower
CC       extent in liver, lung, spleen, brain, skeletal muscle and heart. In
CC       kidney, expressed in proximal tubules at the corticomedullary junction.
CC       Isoform 2 is specifically expressed in kidney. Isoform 1 is expressed
CC       in kidney and pancreas while isoform 3 is specifically expressed in
CC       brain (at protein level). In brain, isoform 1 is expressed in
CC       astrocytes while isoform 3 is expressed in neurons (at protein level).
CC       In the eye, isoform 1 is expressed in cornea, conjunctiva, lens
CC       epithelium, ciliary bodies and retina while isoform 2 is detected only
CC       in the conjunctiva. {ECO:0000269|PubMed:10648705,
CC       ECO:0000269|PubMed:10837348, ECO:0000269|PubMed:11592950,
CC       ECO:0000269|PubMed:12444017, ECO:0000269|PubMed:15329059,
CC       ECO:0000269|PubMed:9486238, ECO:0000269|PubMed:9841505}.
CC   -!- DEVELOPMENTAL STAGE: Expression is first detected at 17 dpc in spinal
CC       cord and starts in forebrain at birth. Higher expression in brain is
CC       detected at postnatal day 15 and persists throughout adulthood.
CC       {ECO:0000269|PubMed:10648705}.
CC   -!- INDUCTION: Down-regulated after cadmium-intoxication and sodium or
CC       bicarbonate loading (at protein level). Down-regulated by HCO3[-]
CC       loading. {ECO:0000269|PubMed:11703600, ECO:0000269|PubMed:15781297,
CC       ECO:0000269|PubMed:9841505}.
CC   -!- PTM: Phosphorylation of Ser-1026 by PKA increases the binding of CA2
CC       and changes the Na(+):HCO3(-) stoichiometry of the transporter from 3:1
CC       to 2:1. Phosphorylated in presence of STK39 and dephosphorylated in
CC       presence of PP1 phosphatase; phosphorylation seems to inhibit SLC4A4
CC       activity. {ECO:0000250|UniProtKB:O88343, ECO:0000250|UniProtKB:Q9Y6R1}.
CC   -!- PTM: [Isoform 2]: N-glycosylation is not necessary for the transporter
CC       basic functions. {ECO:0000269|PubMed:12604466}.
CC   -!- SIMILARITY: Belongs to the anion exchanger (TC 2.A.31) family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF004017; AAC40034.1; -; mRNA.
DR   EMBL; AF027362; AAB83997.1; -; mRNA.
DR   EMBL; AF124441; AAF87312.1; -; mRNA.
DR   EMBL; AF254802; AAF87553.1; -; mRNA.
DR   EMBL; AF210250; AAF21040.1; -; mRNA.
DR   PIR; T13962; T13962.
DR   PIR; T14110; T14110.
DR   RefSeq; NP_445876.1; NM_053424.1. [Q9JI66-1]
DR   RefSeq; XP_006250853.1; XM_006250791.3. [Q9JI66-3]
DR   AlphaFoldDB; Q9JI66; -.
DR   SMR; Q9JI66; -.
DR   BioGRID; 249983; 4.
DR   IntAct; Q9JI66; 2.
DR   MINT; Q9JI66; -.
DR   STRING; 10116.ENSRNOP00000004391; -.
DR   TCDB; 2.A.31.2.2; the anion exchanger (ae) family.
DR   GlyCosmos; Q9JI66; 2 sites, No reported glycans.
DR   iPTMnet; Q9JI66; -.
DR   PhosphoSitePlus; Q9JI66; -.
DR   SwissPalm; Q9JI66; -.
DR   PaxDb; 10116-ENSRNOP00000004391; -.
DR   GeneID; 84484; -.
DR   KEGG; rno:84484; -.
DR   UCSC; RGD:68936; rat. [Q9JI66-1]
DR   AGR; RGD:68936; -.
DR   CTD; 8671; -.
DR   RGD; 68936; Slc4a4.
DR   VEuPathDB; HostDB:ENSRNOG00000003134; -.
DR   eggNOG; KOG1172; Eukaryota.
DR   HOGENOM; CLU_002289_5_0_1; -.
DR   InParanoid; Q9JI66; -.
DR   OrthoDB; 1013180at2759; -.
DR   PhylomeDB; Q9JI66; -.
DR   TreeFam; TF313630; -.
DR   Reactome; R-RNO-425381; Bicarbonate transporters.
DR   PRO; PR:Q9JI66; -.
DR   Proteomes; UP000002494; Chromosome 14.
DR   Bgee; ENSRNOG00000003134; Expressed in adult mammalian kidney and 19 other cell types or tissues.
DR   ExpressionAtlas; Q9JI66; baseline and differential.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISS:UniProtKB.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0016020; C:membrane; IDA:ARUK-UCL.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0008509; F:monoatomic anion transmembrane transporter activity; IEA:InterPro.
DR   GO; GO:0008510; F:sodium:bicarbonate symporter activity; IDA:UniProtKB.
DR   GO; GO:0005452; F:solute:inorganic anion antiporter activity; IEA:InterPro.
DR   GO; GO:0015293; F:symporter activity; ISO:RGD.
DR   GO; GO:0015701; P:bicarbonate transport; ISO:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0072237; P:metanephric proximal tubule development; IEP:RGD.
DR   GO; GO:0045821; P:positive regulation of glycolytic process; ISO:RGD.
DR   GO; GO:0051453; P:regulation of intracellular pH; ISO:RGD.
DR   GO; GO:0042391; P:regulation of membrane potential; ISO:RGD.
DR   GO; GO:0006885; P:regulation of pH; TAS:RGD.
DR   GO; GO:0036376; P:sodium ion export across plasma membrane; ISO:RGD.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; ISO:RGD.
DR   GO; GO:0006814; P:sodium ion transport; ISS:UniProtKB.
DR   GO; GO:0055085; P:transmembrane transport; ISO:RGD.
DR   Gene3D; 1.10.287.570; Helical hairpin bin; 1.
DR   InterPro; IPR013769; Band3_cytoplasmic_dom.
DR   InterPro; IPR011531; HCO3_transpt-like_TM_dom.
DR   InterPro; IPR003020; HCO3_transpt_euk.
DR   InterPro; IPR003024; Na/HCO3_transpt.
DR   InterPro; IPR016152; PTrfase/Anion_transptr.
DR   NCBIfam; TIGR00834; ae; 1.
DR   PANTHER; PTHR11453; ANION EXCHANGE PROTEIN; 1.
DR   PANTHER; PTHR11453:SF10; ELECTROGENIC SODIUM BICARBONATE COTRANSPORTER 1; 1.
DR   Pfam; PF07565; Band_3_cyto; 1.
DR   Pfam; PF00955; HCO3_cotransp; 1.
DR   PRINTS; PR01231; HCO3TRNSPORT.
DR   PRINTS; PR01232; NAHCO3TRSPRT.
DR   SUPFAM; SSF55804; Phoshotransferase/anion transport protein; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Ion transport; Membrane;
KW   Phosphoprotein; Reference proteome; Sodium; Sodium transport; Symport;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..1079
FT                   /note="Electrogenic sodium bicarbonate cotransporter 1"
FT                   /id="PRO_0000079231"
FT   TOPO_DOM        1..466
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   TRANSMEM        467..491
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   TOPO_DOM        492..501
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   TRANSMEM        502..520
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   TOPO_DOM        521
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   TRANSMEM        522..542
FT                   /note="Discontinuously helical; Name=3"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   TOPO_DOM        543..550
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   TRANSMEM        551..571
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   TOPO_DOM        572..585
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   TRANSMEM        586..609
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   TOPO_DOM        610..692
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   TRANSMEM        693..710
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   TOPO_DOM        711..725
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   TRANSMEM        726..745
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   TOPO_DOM        746..779
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   TRANSMEM        780..807
FT                   /note="Helical; Name=8"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   TOPO_DOM        808..819
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   TRANSMEM        820..836
FT                   /note="Helical; Name=9"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   TOPO_DOM        837
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   TRANSMEM        838..855
FT                   /note="Discontinuously helical; Name=10"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   TOPO_DOM        856..877
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   TRANSMEM        878..894
FT                   /note="Helical; Name=11"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   TOPO_DOM        895..901
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   TRANSMEM        902..918
FT                   /note="Helical; Name=12"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   TOPO_DOM        919..960
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   INTRAMEM        961..986
FT                   /note="Discontinuously helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   TOPO_DOM        987..1079
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   REGION          1..62
FT                   /note="Required for interaction with AHCYL1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   REGION          39..78
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          235..266
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          748..779
FT                   /note="Interaction with CA4"
FT                   /evidence="ECO:0000250"
FT   REGION          1002..1004
FT                   /note="CA2-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          1012..1079
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1030..1033
FT                   /note="CA2-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          1057..1059
FT                   /note="Required for basolateral targeting"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        39..53
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        54..73
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        235..260
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1012..1039
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1060..1079
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            636
FT                   /note="Not glycosylated"
FT   MOD_RES         30
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:O88343"
FT   MOD_RES         61
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O88343"
FT   MOD_RES         65
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         68
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         223
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O88343"
FT   MOD_RES         232
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O88343"
FT   MOD_RES         233
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O88343"
FT   MOD_RES         245
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         249
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         254
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         256
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O88343"
FT   MOD_RES         257
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         262
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1026
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6R1"
FT   MOD_RES         1029
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1034
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1044
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O88343"
FT   MOD_RES         1069
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   VAR_SEQ         1..44
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9486238,
FT                   ECO:0000303|PubMed:9841505"
FT                   /id="VSP_016717"
FT   VAR_SEQ         45..85
FT                   /note="HKRKAGHKEKKEKERISENYSDKSDVENADESSSSILKPLI -> MSTENVE
FT                   GKPNNLGERGRARSSTFLRVFQPMFNHSIFTSAV (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9486238,
FT                   ECO:0000303|PubMed:9841505"
FT                   /id="VSP_016718"
FT   VAR_SEQ         1034..1079
FT                   /note="SDCPYSEKVPSIKIPMDITEQQPFLSDNKPLDRERSSTFLERHTSC -> EK
FT                   DPQHSLNATHHADKIPFLESLGLPSPPRSPVKVVPQIRIELESEDNDYLWRNKGTETTL
FT                   (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10837348"
FT                   /id="VSP_016719"
FT   CONFLICT        284..285
FT                   /note="AS -> VP (in Ref. 2; AAB83997 and 4; AAF21040)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        479
FT                   /note="A -> G (in Ref. 2; AAB83997 and 4; AAF21040)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        640
FT                   /note="S -> Y (in Ref. 2; AAB83997)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        655
FT                   /note="S -> F (in Ref. 2; AAB83997)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        803
FT                   /note="A -> P (in Ref. 2; AAB83997 and 4; AAF21040)"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         Q9JI66-2:2
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CARBOHYD        Q9JI66-2:597
FT                   /note="N-linked (GlcNAc) asparagine"
FT                   /evidence="ECO:0000269|PubMed:12604466"
FT   CARBOHYD        Q9JI66-2:617
FT                   /note="N-linked (GlcNAc) asparagine"
FT                   /evidence="ECO:0000269|PubMed:12604466"
FT   MUTAGEN         Q9JI66-2:33
FT                   /note="N->Q: No effect on N-glycosylation."
FT                   /evidence="ECO:0000269|PubMed:12604466"
FT   MUTAGEN         Q9JI66-2:199
FT                   /note="N->Q: No effect on N-glycosylation."
FT                   /evidence="ECO:0000269|PubMed:12604466"
FT   MUTAGEN         Q9JI66-2:208
FT                   /note="N->Q: No effect on N-glycosylation."
FT                   /evidence="ECO:0000269|PubMed:12604466"
FT   MUTAGEN         Q9JI66-2:497
FT                   /note="N->Q: No effect on N-glycosylation."
FT                   /evidence="ECO:0000269|PubMed:12604466"
FT   MUTAGEN         Q9JI66-2:592
FT                   /note="N->Q: No effect on N-glycosylation. Complete loss of
FT                   N-glycosylation without effect on transporter basic
FT                   function; when associated with Q-597 and Q-617."
FT                   /evidence="ECO:0000269|PubMed:12604466"
FT   MUTAGEN         Q9JI66-2:597
FT                   /note="N->Q: Reduces the extent of N-glycosylation.
FT                   Complete loss of N-glycosylation without effect on
FT                   transporter basic function; when associated with Q-592 and
FT                   Q-617."
FT                   /evidence="ECO:0000269|PubMed:12604466"
FT   MUTAGEN         Q9JI66-2:617
FT                   /note="N->Q: Reduces the extent of N-glycosylation.
FT                   Complete loss of N-glycosylation without effect on
FT                   transporter basic function; when associated with Q-592 and
FT                   Q-597."
FT                   /evidence="ECO:0000269|PubMed:12604466"
FT   MOD_RES         Q9JI66-3:1026
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         Q9JI66-3:1029
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         Q9JI66-3:1060
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         Q9JI66-3:1064
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         Q9JI66-3:1078
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   1079 AA;  121343 MW;  F5A187AFE41BA5B4 CRC64;
     MEDEAVLDRG ASFLKHVCDE EEVEGHHTIY IGVHVPKSYR RRRRHKRKAG HKEKKEKERI
     SENYSDKSDV ENADESSSSI LKPLISPAAE RIRFILGEED DSPAPPQLFT ELDELLAVDG
     QEMEWKETAR WIKFEEKVEQ GGERWSKPHV ATLSLHSLFE LRTCMEKGSI MLDREASSLP
     QLVEMIADHQ IETGLLKPDL KDKVTYTLLR KHRHQTKKSN LRSLADIGKT VSSASRMFSN
     PDNGSPAMTH RNLTSSSLND ISDKPEKDQL KNKFMKKLPR DAEASNVLVG EVDFLDTPFI
     AFVRLQQAVM LGALTEVPVP TRFLFILLGP KGKAKSYHEI GRAIATLMSD EVFHDIAYKA
     KDRHDLIAGI DEFLDEVIVL PPGEWDPAIR IEPPKSLPSS DKRKNMYSGG ENVQMNGDTP
     HDGGHGGGGH GDCEELQRTG RFCGGLIKDI KRKAPFFASD FYDALNIQAL SAILFIYLAT
     VTNAITFGGL LGDATDNMQG VLESFLGTAV SGAIFCLFAG QPLTILSSTG PVLVFERLLF
     NFSKDHSFDY LEFRLWIGLW SAFMCLILVA TDASFLVQYF TRFTEEGFSS LISFIFIYDA
     FKKMIKLADY YPINSDFRVG YNTHFSCACL PPDPVNLSVS NDTTLAPEDL PTVSSTDMYH
     NATFDWAYLS KKECVKFGGK LVGNNCDFVP DITLMSFILF LGTYTSSMAM KKFKTSRYFP
     TTARKLISDF AIILSILIFC VIDALVGVDT PKLIVPSEFK PTSPHRGWFV PPFGGNPWWV
     CLAAAIPALL VTILIFMDQQ ITAVIVNRKE HKLKKGAGYH LDLFWVAILM VVCSFMALPW
     YVAATVISIA HIDSLKMETE TSAPGEQPKF LGVREQRVTG TLVFILTGLS VFMAPILKFI
     PMPVLYGVFL YMGVASLNGV QFMDRLKLLL MPLKHQPDFI YLRHVPLRRV HLFTSLQVLC
     LALLWILKST VAAIIFPVMI LALVAVRKGM DYLFSQHDLS FLDDVIPEKD KKKKEDEKKK
     KKKKGSLDSD NDDSDCPYSE KVPSIKIPMD ITEQQPFLSD NKPLDRERSS TFLERHTSC
//
